Jordan E Pinsker
Overview
Explore the profile of Jordan E Pinsker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
1452
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brown S, Laffel L, Akturk H, Forlenza G, Shah V, Wadwa R, et al.
Diabetes Technol Ther
. 2024 Nov;
PMID: 39601043
We evaluated a modified version of Control-IQ technology with a lower treatment range and a modified meal bolus module in adults, adolescents, children, and preschoolers with type 1 diabetes in...
2.
Akturk H, Karakus K, DSouza E, Assadi K, Pinsker J, Messer L
J Diabetes Sci Technol
. 2024 Nov;
19(2):582-583.
PMID: 39587715
No abstract available.
3.
Beck R, Levy C, Kudva Y, Pandit K, Blevins T, Raghinaru D, et al.
Clin Diabetes
. 2024 Oct;
42(4):547-549.
PMID: 39429449
No abstract available.
4.
Messer L, Welsh J, Habif S, Pinsker J, Walker T
J Diabetes Sci Technol
. 2024 May;
18(5):1265-1266.
PMID: 38801205
No abstract available.
5.
Kaur R, Levy C, Castorino K, Wood-Wentz C, Rizvi S, Ozaslan B, et al.
J Endocr Soc
. 2024 May;
8(6):bvae071.
PMID: 38721109
Background: Customized and standard automated insulin delivery (AID) systems for use in pregnancies of women with preexisting type 1 diabetes (T1D) are being developed and tested to achieve pregnancy appropriate...
6.
Levy C, Bailey R, Laffel L, Forlenza G, DiMeglio L, Hughes M, et al.
Diabetes Technol Ther
. 2024 May;
26(9):652-660.
PMID: 38696672
To evaluate the safety and explore the efficacy of use of ultra-rapid lispro (URLi, Lyumjev) insulin in the Tandem t:slim X2 insulin pump with Control-IQ 1.5 technology in children, teenagers,...
7.
Carlson A, Graham T, Akturk H, Liljenquist D, Bergenstal R, Sulik B, et al.
J Diabetes Sci Technol
. 2024 Mar;
18(6):1288-1292.
PMID: 38439656
Background: Control-IQ technology version 1.5 allows for a wider range of weight and total daily insulin (TDI) entry, in addition to other changes to enhance performance for users with high...
8.
Shah V, Akturk H, Trahan A, Piquette N, Wheatcroft A, Schertz E, et al.
J Diabetes Sci Technol
. 2024 Feb;
18(6):1281-1287.
PMID: 38323362
Background: Optimization of automated insulin delivery (AID) settings is required to achieve desirable glycemic outcomes. We evaluated safety and efficacy of a computerized system to initialize and adjust insulin delivery...
9.
Graham R, Mueller L, Manning M, Habif S, Messer L, Pinsker J, et al.
Diabetes Technol Ther
. 2023 Oct;
26(1):24-32.
PMID: 37782904
Severe hypoglycemia (SH) and diabetic ketoacidosis (DKA) remain significant risks with intensive insulin therapy. While these adverse event (AE) rates are generally very low in advanced hybrid closed-loop (AHCL) clinical...
10.
Messer L, DSouza E, Merchant G, Mueller L, Farnan J, Habif S, et al.
J Diabetes Sci Technol
. 2023 Aug;
18(1):10-13.
PMID: 37605474
Background: The t:connect mobile app from Tandem Diabetes Care recently added a feature to allow t:slim X2 insulin pump users to initiate an insulin bolus from their personal smartphone. User...